Pressure Biosciences (PBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PBIO | TMO | ISRG | EW | DXCM |
| Company | Pressure Biosciences | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Dexcom Inc |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 0.2500 | 559.04 | 376.63 | 89.09 | 135.29 |
| High | 0.2500 | 559.04 | 383.85 | 90.40 | 137.82 |
| Low | 0.2190 | 552.68 | 371.54 | 87.87 | 133.21 |
| Last | 0.2500 | 554.55 | 378.55 | 90.05 | 136.52 |
| Change | +0.0003 | -3.32 | +1.19 | +0.85 | +1.96 |
| % Change | +0.12% | -0.60% | +0.32% | +0.95% | +1.46% |
| Volume | 43,225 | 1,010,297 | 1,602,971 | 2,640,500 | 3,036,322 |
| 20-Day Average Volume | 114,016 | 1,166,165 | 1,375,139 | 3,076,990 | 2,389,226 |
| Previous Close | 0.2497 | 557.87 | 377.36 | 89.20 | 134.56 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2109 | 575.10 | 389.14 | 92.82 | 137.22 |
| 20-Day Raw Stochastic | 64.71% | 5.01% | 21.76% | 26.42% | 48.74% |
| 20-Day Relative Strength | 53.10% | 41.99% | 46.04% | 49.93% | 54.97% |
| Weighted Alpha | -86.77 | +1.02 | +28.42 | +11.39 | +20.00 |
| Today's Opinion | 56% Sell | 56% Buy | 56% Buy | 72% Buy | 88% Buy |
| Previous Opinion | 56% Sell | 56% Buy | 56% Buy | 56% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 88% Buy | 100% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.70% since 04/09/24 | -5.88% since 04/09/24 | -3.17% since 04/09/24 | -3.22% since 04/09/24 | -2.80% since 04/09/24 |
| Low | 0.2098 on 04/11/24 | 552.68 on 04/16/24 | 371.54 on 04/16/24 | 87.87 on 04/16/24 | 133.21 on 04/16/24 |
| High | 0.3100 on 04/12/24 | 580.35 on 04/11/24 | 392.80 on 04/11/24 | 92.99 on 04/11/24 | 141.25 on 04/11/24 |
| 1-Month | |||||
| %Chg | +40.45% since 03/15/24 | -5.07% since 03/15/24 | -4.47% since 03/15/24 | -2.45% since 03/15/24 | +4.65% since 03/15/24 |
| Low | 0.1400 on 03/20/24 | 552.68 on 04/16/24 | 371.54 on 04/16/24 | 87.87 on 04/16/24 | 131.31 on 03/20/24 |
| High | 0.3100 on 04/12/24 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 3-Month | |||||
| %Chg | -34.21% since 01/16/24 | +2.32% since 01/16/24 | +4.48% since 01/16/24 | +21.71% since 01/16/24 | +9.69% since 01/16/24 |
| Low | 0.1400 on 03/20/24 | 534.24 on 02/01/24 | 355.17 on 01/17/24 | 71.92 on 01/25/24 | 113.05 on 02/28/24 |
| High | 0.4800 on 01/22/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 6-Month | |||||
| %Chg | +25.00% since 10/16/23 | +13.51% since 10/16/23 | +38.08% since 10/16/23 | +26.35% since 10/16/23 | +72.92% since 10/16/23 |
| Low | 0.1400 on 03/20/24 | 415.60 on 10/25/23 | 254.85 on 10/30/23 | 60.57 on 10/30/23 | 76.81 on 10/17/23 |
| High | 0.8000 on 10/25/23 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,538 | 212,946,784 | 133,754,872 | 53,691,884 | 51,874,900 |
| Shares Outstanding, K | 34,195 | 381,714 | 354,449 | 601,927 | 385,515 |
| Annual Sales | 1,730,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,622,300,000 |
| Annual Net Income | -16,080,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 541,500,000 |
| Last Quarter Sales | 410,000 | 10,886,000,000 | 1,928,300,000 | 1,534,100,000 | 1,034,500,000 |
| Last Quarter Net Income | -5,630,000 | 1,630,000,000 | 606,200,000 | 369,900,000 | 256,300,000 |
| 60-Month Beta | -0.11 | 0.80 | 1.36 | 1.05 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.29 on 11/20/23 | 5.67 on 01/31/24 | 1.60 on 01/23/24 | 0.64 on 02/06/24 | 0.50 on 02/08/24 |
| Latest Earnings Date | 05/21/24 | 04/24/24 | 04/18/24 | 04/25/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.24 | 85.13 | 35.97 | 90.16 |